Evidence map›Paper›PMID 32103995›Full record

ArticleOncoTargets and therapy2020

Long Noncoding RNA X-Inactive Specific Transcript Facilitates Cellular Functions in Melanoma via miR-139-5p/ROCK1 Pathway.

Ke Tian, Dongxia Sun, Min Chen, Yifei Yang, Fang Wang, Taotao Guo, Zhimin Shi

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in OncoTargets and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Pyroptosis: mechanisms and diseases.Signal transduction and targeted therapy · 2021
    Review
  8. Article
  9. Biological Function of Long Non-coding RNA (LncRNA) Xist.Frontiers in cell and developmental biology · 2021
    Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ke Tian *Department of Dermatology, Affiliated Hospital of Hebei University of Engineering, Handan 056000, Hebei Province, People's Republic of China.
Dongxia Sun *Department of Pathology, Handan Maternal and Child Health Hospital, Handan 056000, Hebei Province, People's Republic of China.
Min ChenDepartment of Pathology, Handan Maternal and Child Health Hospital, Handan 056000, Hebei Province, People's Republic of China.
Yifei YangDepartment of Dermatology, Affiliated Hospital of Hebei University of Engineering, Handan 056000, Hebei Province, People's Republic of China.
Fang WangDepartment of Pathology, Medical College, Hebei University of Engineering, Handan 056000, Hebei Province, People's Republic of China.
Taotao GuoLaboratory Department, Handan Second Hospital, Handan, Hebei Province 056000, People's Republic of China.
Zhimin ShiDepartment of Pathology, Medical College, Hebei University of Engineering, Handan 056000, Hebei Province, People's Republic of China.ORCID 0000-0001-8292-6672
Hebei University of Engineering · CNHandan College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlthough X-inactive specific transcript (XIST) is known to play a critical role in the pathogenesis of melanoma, the mechanisms through which this remains unclear.

methodsRNAseq, immunohistochemistry, and qRT-PCR were used to identify the levels of XIST, miR-139-5p, and Rho-Associated Coiled-Coil Containing Protein Kinase-1 (ROCK1) in melanoma tissues and cells. A subcellular fractionation assay was used to determine the location of XIST. CCK-8 and colony formation assays were used to evaluate cellular proliferation. Cell migration and wound healing assays were used to detect the effects on cell migration. RNA pull-down was used to confirm the interaction between XIST and miR-139-5p. Besides, the xenograft tumor experiment was performed to further verify the roles of XIST in melanoma.

resultsIn this study, an increased level of XIST was revealed in melanoma tissues and cells, which was associated with higher TNM stage and positive lymph node metastasis. XIST was found to function as a "molecular sponge" of miR-139-5p to facilitate cellular functions. Moreover, these consequences could be partially reversed by inhibition of miR-139-5p. MiR-139-5p was found to target ROCK1 directly, leading to suppression of ROCK1 expression; this effect could be partially reversed by inhibiting XIST expression. Furthermore, the deletion of ROCK1 induced anti-oncogenic effects similar to those seen with knockout of XIST. Upregulation of miR-139-5p and knockdown of XIST could inhibit cell functions in melanoma.

conclusionOur findings suggested that the lncRNA XIST facilitates cellular functions in melanoma via the miR-139-5p/ROCK1 pathway.

Indexed as

LncRNAmelanomaMiR-139-5pROCK1XIST

Identifiers

PMID32103995
PMCPMC7024886
OpenAlexW3006574387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.